Berrin Oezlem Schwenk Cardiovascular Specialist
About Berrin Oezlem Schwenk Cardiovascular Specialist
Berrin Oezlem Schwenk is a Senior Product Manager at Bristol-Myers Squibb, specializing in cardiovascular products, particularly Eliquis (Apixaban). She has extensive experience in product management and marketing within the pharmaceutical industry.
Company
Berrin Oezlem Schwenk is currently working at Bristol-Myers Squibb as the Senior Product Manager for Cardiovascular, specifically focused on Eliquis (Apixaban). Her office is based in Cham, Switzerland. She is responsible for various strategic activities, including launching new indications for Eliquis and managing long-term sales forecasts and marketing budgets.
Title
Berrin Oezlem Schwenk holds the position of Senior Product Manager, Cardiovascular, at Bristol-Myers Squibb. In this role, she focuses on developing and implementing strategies for Eliquis (Apixaban) to enhance its market presence and value communication among physicians.
Education and Expertise
Berrin Oezlem Schwenk has pursued an extensive educational path, acquiring diverse qualifications relevant to her field. She studied Cardiology at the University of Gothenburg, earning an EBAC Attendance Certificate. She has also completed various other courses, including Pharma Produktmarketing at PharmaPraxis, and Forecasting & Finance - Effective Communication at GalbraithWight / Building Blocks. Additionally, she holds an Advanced Federal Diploma in Marketing from Business School KV Aarau and a Certificate in International Business & Export from Vienna University of Economics & Business. Her foundational education includes a Bachelor of Arts & Sociology from Bosphorus University.
Professional Background
Berrin Oezlem Schwenk has a robust professional background in the pharmaceutical and cardiovascular sectors. Her previous roles include Product Manager BU – RX Generics / Cardiovascular at Spirig Healthcare AG, Brand Marketing Manager during a sabbatical leave, and Brand Team Leader for Crestor (Rosuvastatin) at AstraZeneca Pharmaceuticals. She also served as Global Marketing Managerin for Vascular Intervention at BIOTRONIK and held positions in electronics product management at Excom AG and Karma GmbH.
Key Achievements
At Bristol-Myers Squibb, Berrin Oezlem Schwenk has developed and launched an emotional patient-centric campaign for Eliquis, significantly enhancing its value story to physicians. She has played a pivotal role in the growth of Eliquis in the Swiss market by implementing a multichannel communication strategy and establishing a strong brand positioning. She is actively involved in various projects like Marketing Excellence and local implementation of global strategies, supporting Eliquis' ambition of achieving market leadership.